If adverse drug reactions occur, contact your healthcare professional, pharmacist, or directly to the information database on adverse drug reactions (actions), including reports of drug ineffectiveness RSE on REM "National Center for Expertise of Medicines and Medical Devices" of the Committee for Medical and Pharmaceutical Control of the Ministry of Health of the Republic of Kazakhstan additional information Composition of the medicinal product One bottle contains: active substance: reduced glutathione sodium salt - 0.646 g, corresponds to 600 mg reduced glutathione one ampoule with solvent contains: water for injection Release form and packaging 0.646 g of the drug is placed in a transparent glass bottle, sealed with a rubber stopper and sealed with an aluminum cap
OCA is an agonist of FXR (Farnesoid X receptor)
Czechia 99.7 % purity confirmed by COA Assay content verified at 102.5 mg Endotoxin level below 0.001 EU/mg No detectable heavy metals or microbial contamination High-purity peptide for controlled laboratory research For research use only not for human or veterinary use For laboratory research only
In this guide, we break down how these peptides work, what the evidence says about dosing, what results to expect and when, and what side effects you should watch for, so you can make a fully informed decision before starting therapy
